Trial
NCT05862766
Isatuximab in Lung Transplant Recipients
Early Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
NYU Langone Health
Collaborators
—
Condition
Antibody-mediated Rejection
Intervention
Isatuximab
Why stopped
Study no longer had funding and therefore was closed before enrollment began.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-04-11